Log In
Print
BCIQ
Print
Print this Print this
 

GDC-0623

  Manage Alerts
Collapse Summary General Information
Company Genentech Inc.
DescriptionMEK inhibitor
Molecular Target MEK
Mechanism of ActionMEK inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationSolid tumors
Indication DetailsTreat solid tumors
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today